SCHEMBL6436476

SCHEMBL6436476

BrCC/C=C/CCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6594452 0.88
SCHEMBL7218328 0.88
SCHEMBL6594457 0.88
SCHEMBL28999233 0.84
SCHEMBL25216887 0.82
SCHEMBL17784465 0.82
SCHEMBL3307320 0.82
SCHEMBL3307326 0.82
SCHEMBL7521428 0.82
SCHEMBL25246419 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113861816-B Organic silicon modified PAE polyurea coating 浙江艾特普科技有限公司 2022-07-01 CN claimed
CN-113861816-A Organic silicon modified PAE polyurea coating 浙江艾特普科技有限公司 2021-12-31 CN claimed
EP-3583088-B1 SYNTHESIS OF PHEROMONES AND RELATED MATERIALS VIA OLEFIN METATHESIS PROVIVI INC (US) 2025-09-10 EP disclosed
US-20250243427-A1 PRECURSORS OF PHENOLIC FRAGRANT COMPOUNDS GIVAUDAN SA (CH) 2025-07-31 US disclosed
US-12304898-B2 Quinolyl-containing compound and pharmaceutical composition, and use thereof PRIMEGENE (BEIJING) CO., LTD. (CN) 2025-05-20 US disclosed
CN-118742539-A Heterocyclic derivative and preparation method and application thereof 浙江海正药业股份有限公司 2024-10-01 CN disclosed
WO-2024140595-A1 TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 珂阑(上海)医药科技有限公司 2024-07-04 WO disclosed
CN-118255685-A Tricyclic compound, pharmaceutical composition and application thereof 珂阑(上海)医药科技有限公司 2024-06-28 CN disclosed
CN-118119588-A Precursors for phenolic aromatic compounds 奇华顿股份有限公司 2024-05-31 CN disclosed
CN-116063626-B Anti-calcium shrinkage and expansion agent and preparation method and application thereof 中国石油化工股份有限公司 2024-05-07 CN disclosed
CN-113924288-B Quinolinyl-containing compound, pharmaceutical composition and application thereof 北京普祺医药科技股份有限公司 2024-04-05 CN disclosed
EP-1230207-B1 METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS PEDERSON RICHARD L (US) 2005-06-22 EP disclosed
US-6696597-B2 CROSS-METATHESIZING A TERMINAL OLEFIN AND INTERNAL OLEFIN IN PRESENCE OF CATALYST, TO FORM METATHESIS PRODUCT AND A SIDE PRODUCT; APPLYING CONDITIONS OF SUFFICIENTLY HIGH TEMPERATURE AND/OR LOW PRESSURE TO EVAPORTE SIDE PRODUCT TILLIECHEM, INC. 2004-02-24 US disclosed
EP-1230207-A2 METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS Pederson, Richard L. (US) 2002-08-14 EP disclosed
US-20020022741-A1 Metathesis syntheses of pheromones or their components MATERIA, INC. 2002-02-21 US disclosed
WO-2001036368-A2 METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS PEDERSON RICHARD L (US) 2001-05-25 WO disclosed
US-5023378-A Hypotensive agents, antiischemic agents, urogenital disorders GLAXO GROUP LIMITED (GB) 1991-06-11 US disclosed
EP-0188361-B1 AMINE DERIVATIVES GLAXO GROUP LIMITED (GB) 1991-03-06 EP disclosed
EP-0188361-A1 Amine derivatives GLAXO GROUP LIMITED (GB) 1986-07-23 EP disclosed
US-3997669-A ANTIINFLAMMATORY CIBA-GEIGY CORPORATION (US) 1976-12-14 US disclosed